We are live on ! Find out more
DGX icon

Quest Diagnostics

815 hedge funds and large institutions have $13.2B invested in Quest Diagnostics in 2024 Q1 according to their latest regulatory filings, with 75 funds opening new positions, 263 increasing their positions, 313 reducing their positions, and 90 closing their positions.

New
Increased
Maintained
Reduced
Closed

117% more call options, than puts

Call options by funds: $149M | Put options by funds: $68.6M

16% more capital inflows, than outflows

Capital inflows: $1.22B | Capital outflows: $1.06B

2.79% more ownership

Funds ownership: 86.89% → 89.68% (+2.8%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

1% less funds holding

Funds holding: 826 → 815 (-11)

16% less repeat investments, than reductions

Existing positions increased: 263 | Existing positions reduced: 313

17% less first-time investments, than exits

New positions opened: 75 | Existing positions closed: 90

Holders
815
Holders Change
-11
Holders Change %
-1.33%
% of All Funds
11.7%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
75
Increased
263
Reduced
313
Closed
90
Calls
$149​M
Puts
$68.6​M
Net Calls
+$80.1​M
Net Calls Change
-⁠$17.6​M

DGX Hedge Fund Activity: Q1 2024 in Review

815 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q1 2024, worth a combined $13.2B — down 2% from $13.5B a quarter earlier.

Sellers outnumbered buyers: 90 funds closed out of DGX and 75 opened new positions — a net loss of 15 holders — while 313 trimmed existing stakes and 263 added.

The largest buyer was Fiduciary Management Inc, opening a new position worth an estimated $194M. The largest seller was T. Rowe Price Associates, cutting an estimated $318M.

  • 815 institutional investors held Quest Diagnostics (DGX) as of Q1 2024, down from 826 in Q4 2023.
  • Funds reported $13.2B of Quest Diagnostics stock for Q1 2024, down 2% quarter-over-quarter.
  • 75 funds opened new Quest Diagnostics positions in Q1 2024 and 90 closed out, a net change of -15 holders.
  • The largest Quest Diagnostics buyer in Q1 2024 was Fiduciary Management Inc, an estimated $194M added.
  • The largest Quest Diagnostics seller in Q1 2024 was T. Rowe Price Associates, an estimated $318M sold.

Based on aggregated 13F filings for Q1 2024.